ADM increased the dividend by 4.48% making this dividend champion‘s 44th consecutive dividend increase. The old dividend rate was 1.34 annual dividend payout (0.335 quarterly), the new rate is 1.40 (0.35 quarterly). Our current fair value of the company is $28.22 a share so at the current price of $42.44 the stock is overvalued and Continue reading →
Making 45% Annually Trading Options Against Dividend Growth Stocks
Archive for 2019
ADDING AT&T (T) SHARES
We closed our books last week revealing that we made over $2,600 in January (after quite slow start) which allowed us to invest some of the proceeds into good dividend growth stocks. We use 50% of the options trading proceeds to buy DGI stocks according to our watch list. Whenever a stock is marked as Continue reading →
Adding STX shares to our portfolio
We have a strategy to use 50% of options trading proceeds to purchase dividend stocks. In this market many of the stocks in our watch list are a “buy”, so it is difficult to pick one (I wish we had more cash to accumulate them all). Originally, I wanted to add AAPL but we were Continue reading →
Realty Income (O) Announces 3% Dividend Increase
Realty Income Corporation (NYSE: O), The Monthly Dividend Company®, today announced its Board of Directors has declared an increase in the company’s common stock monthly cash dividend to $0.2255 per share from $0.2210 per share. The dividend is payable on February 15, 2019 to shareholders of record as of February 1, 2019. This is the Continue reading →
Boeing raises dividends by 20.18%
Boeing (NYSE: BA) has an impressive dividend growth rate of 27.50% (5 year annual average). And in January 2019 it increased the dividend by 20.18% from $6.84 annual dividend (1.710 quarterly rate) to $8.22 (2.055 quarterly) dividend rate payable in March 1st, 2019. Boeing is a dividend challenger with 8 years of consecutive dividend increases Continue reading →
Abbott Labs raises dividends by 14.29%
Abbott Laboratories (NYSE: ABT) raised their dividend by 14.29% to $0.320 a share with ex-date on January 14th, 2019 and pay date on February 15th, 2019 from previous $0.280 a share dividend rate. This makes ABT a dividend challenger with a track record of 7 consecutive years of dividend increases. However, in our watch list, Continue reading →
Johnson & Johnson boosts prices on top-selling drugs
Joining a number of other drugmakers this month, Johnson & Johnson (NYSE:JNJ) raised prices on about two dozen prescription drugs today, including top sellers Stelara (for psoriasis), Zytiga (for prostate cancer) and blood thinner Xarelto. Most increases were in the 6-7% range, Reuters notes. The company says average list price increase on its drugs will Continue reading →
Recent Comments